Embed Size (px)
Citation preview
466th OMICS International Conference
Blood Malignancies & TreatmentApril 18-19, 2016 Dubai, UAE
4th International Conference on
conferenceseries.com
Scientific Program
OMICS International Conferences2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Phone: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Email: [email protected], [email protected]
Page 2
Keynote Forum10:30 -10:35 Introduction
10:35 -11:05Innovative immunotherapy for prevention and treatment of relapse following conventional chemotherapy or stem cell transplantationShimon Slavin, International Center for Cell Therapy & Cancer Immunotherapy, Israel
Networking & Refreshment Break: 11:05-11:20 @ FoyerSession Introduction
Track 1 : Blood Malignancies Track 2 : LeukemiaSession Chair: John Batchelor, Central Manchester Foundation Trust, UKSession Co-Chair: Slobodanka Ostojic Kolonic, Clinical Hospital Merkur, Croatia
11:20-11:40Title: The pathogenesis of spontaneous intracranial haemorrhage in patients with haematological malignancy John Batchelor, Central Manchester Foundation Trust, UK
11:40-12:00Title: Stratifying patients for immune checkpoint blockade cancer therapiesJean Jacques Fournié, Cancer Research Center of Toulouse, France
12:00-12:20Title: Rituximab maintenance in follicular lymphomaSlobodanka Ostojic Kolonic, Clinical Hospital Merkur, Croatia
12:20-12:40Title: Systemic AL amyloidosis - Novel approaches to treatmentAshutosh Wechalekar, University College London, UK
Group PhotoLunch Break: 12:40-13:40 @ Foyer
13:40-14:00Title: Acute myeloid leukemia in the elderlyMichael Keng, University of Virginia, USA
14:00-14:20Title: Stem cells microenvironment and its effects on leukemia treatmentMalak Yahia Qattan, King Saud University, Saudi Arabia
Panel DiscussionSession Introduction
Track 3 : MyelomaTrack 4 : Myelodysplastic SyndromeTrack 5 : Childhood Hematological CancersSession Chair: Inga Mandac Rogulj, Clinical Hospital Merkur, Croatia
14:20-14:40Title: Management of higher risk myelodysplastic syndromeInga Mandac Rogulj, Clinical Hospital Merkur, Croatia
14:40-15:00Title: Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patientsLamya Mohamed Ibrahim, Advanced Center For Daycare Surgery, UAE
15:00-15:20Title: Recent advances in the diagnosis of multiple myelomaChayya Rani Sherva, MLB Medical College, India
15:20-15:40Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia
09:00-10:00 Registrations Open
Day 1Monday, April 18, 2016
Scientific Program
Opening Ceremony10:00-10:30conferenceseries.com
Page 2
Meeting Room 10
Page 3
Networking & Refreshment Break: 15:40-15:55 @ Foyer
15:55-16:15Title: Treatment and survival in patients with chronic myeloid leukemia in chronic phase (CML-CP) in West IranMehrdad Payandeh, Kermanshah University of Medical Sciences, Iran
16:15-16:35Title: Report of 20 years’ experience on the effect of intensive intrathecal hemotherapy on prognosis of childhood lymphoblastic leukemia with central nervous system (CNS) involvementMahdi Shahriari, Shiraz University of Medical Sciences, Iran
16:35-16:55Title:Biological and molecular effects of selective inhibitor of ‘Aurora Kinase B’ (Barasertib) on a human promyelocytic leukemia cell lineFarhad Zaker, Iran University of Medical Sciences, Iran
Panel Discussion
Day 2Meeting Room 10
Tuesday, April 19, 2016Session Introduction
Track 6 : Blood Cancer DiagnosisTrack 7 : Blood Cancer : Causes & SymptomsTrack 8 : Blood Cancer StagingSession Chair: Elena Zakharova, Botkin Memorial Teaching Hospital, Russia
10:00-10:20Title: Renal consequences of blood malignancies Elena Zakharova, Botkin Memorial Teaching Hospital, Russia
10:20-10:40
Title: Retrospective analysis of allele specific oligonucleotide-polymerase chain reaction , as method for detection three BCR-ABL linase mutations (T315I, M351T AND F311L) in chronic myelogenous leukemia patients treated with Imatinib Mesylate (TKI).Mukul Arvind Gharote, Gujarat Cancer Research Institute, India
Networking & Refreshment Break: 10:40-10:55 @ Foyer
10:55-11:15Title: How to overcome challenges met with during chemotherapy for childhood acute myeloid leukemiaTaha Khattab, King Salman Military Hospital, Saudi Arabia
11:15-11:35Title: Cytogenetic heterogeneity as a prognostic indicator in acute myeloid leukemia patients from India Pina J Trivedi, Gujarat Cancer Research Institute, India
11:35-11:55Title: Phase III of study of R-CHOP-21 vs. R-CHOP-14 for untreated stage III and IV B-cell non-hodgkin's lymphoma: A report from IranMehrdad Payandeh, Kermanshah University of Medical Sciences, Iran
Session IntroductionTrack 9 : Blood Cancer : Treatment & CareTrack 10 : Bone Marrow Transplantation & SurgeryTrack 11 : Blood Cancer : Other AspectsSession Chair: Al-Jawhara Al-Manea, King Fahad Military Hospital, Saudi Arabia
11:55-12:15Title: Hematopoietic stem cell transplantation (HSCT) in childhood leukemiaAl-Jawhara Al-Manea, King Fahad Military Hospital, Saudi Arabia
12:15-12:35Title: Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHLLamiss Mohamed Abd Elaziz, Tanta university, Egypt
Lunch Break: 12:35-13:35 @ Foyer
13:35-13:55Title: BAX gene as a novel expressed tumor associated antigen in acute lymphoblastic leukemiaAmr Mohamed Gawaly, Tanta University, Egypt
13:55-14:15Title: The possible involvement of epstein–barr virus in the etiology of leukemia in sudanese patientsHaitham Eltigani Mohammed Ealawad, Omdurman Islamic University, Sudan
Page 4
Website: http://bloodmalignancies.conferenceseries.com/
OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS International5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS InternationalSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Bookmark your dates7th International Conference on
May 25-26, 2017 London, UKBlood Cancer & Treatment
14:15-14:35Title: Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individualsMahdi Shahriari, Shiraz University of Medical Sciences, Iran
Young Researchers Forum
14:35-14:50Title: Interrelationships among regulatory cells in patients with lymphoproliferative disordersZahra Al-Qarni, Sultan Qaboos University, Oman
14:50-15:05Title: Timely strategies by oncology pharmacist to combat drug shortagesNaureen Wajid, American Hospital Dubai, UAE
15:05-15:20Title: Assessment of responsiveness in non-hodgkin lymphoma patients treated with chemotherapy in King Abdulaziz Hospital-Al Ahsa, KSAAreeg Bala Elbahsire Moahmed Ahmed, King Abdulaziz Hospital-Al Ahsa, KSA
15:20-15:35Title: Clinical characteristics and outcome of acute lymphoblastic leukemia in children in King Abdulaziz Medical City RiyadhTalal Hussein Alshareef, King Saud bin Abdulaziz University for Health Sciences, KSA
Networking & Refreshment Break: 15:35-15:50 @ FoyerPoster Session 15:35-16:15
BC-01Title: Frondoside a potentiates the effects of conventional therapeutic agents in acute leukemiaFatma H Sajwani, United Arab Emirates University, UAE
BC-02Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia
BC-03Title: Mucocutaneous relapse as unusual presentation of T-lineage acute lymphoblastic leukemiaMahdi Shahriari, Shiraz University of Medical Sciences, Iran
BC-04Title: Umbilical cord derived mesenchymal stem cell enhanced the expression of myeloid lineage related antigens on differentiated hematopoietic stem cellMohadese Hashem Boroojerdi, University Putra Malaysia, Malaysia
BC-05Title: Hypothesis: Fingolimod could lift the burden of lymphomaArsalan Azimi, Shiraz University of Medical Sciences, Iran
Awards CeremonyPanel Discussion
Thanks giving & Closing ceremony
